1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
2025 cycle closed March 12, 2025. LOI window was February 19 – March 12, 2025; fellowship term September 1, 2025 – August 31, 2026.
"SITC-Merck Cancer Immunotherapy Clinical Fellowship" is currently closed and not accepting applications.
SITC-Merck Cancer Immunotherapy Clinical Fellowship is sponsored by Society for Immunotherapy of Cancer (SITC) in partnership with Merck. This one-year program is designed to accelerate the careers of early-stage physician-scientists focused on the clinical translation of cancer immunotherapy. It supports innovative clinical or translational research that addresses critical challenges in immune-oncology.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Fellowships - Society for Immunotherapy of Cancer (SITC) - OLD Skip auxiliary navigation (Press Enter). The Society for Immunotherapy of Cancer’s (SITC) Fellowships program was established through the Forward Fund to support the development of early career scientists in the field to cultivate the next generation of cancer immunotherapy experts.
Since 2014, SITC has awarded more than $6 million in fellowships to deserving early career investigators. Application Process and Timeline 2025 Fellowship Opportunities Guidelines Join or Renew Membership 2025 SITC Fellowship opportunities closed March 12.
The SITC Fellowship application is made up of two stages: Stage 1— Letter of Intent (LOI) : In the initial stage, applicants are required to submit a completed application form, an abstract, a biosketch, and a Mentor’s Statement of Support. The Awards Review Committee will review LOI’s and will determine which applicants move to the second stage.
Stage 2— Full Application : Applicants that are selected to move onto the second stage will be notified according to the timeline below. Applicants selected to for the second stage will need to provide an applicant's statement of purpose, mentor's biosketch, institutional letter of support, research plan and budget, facilities, and two personal references.
Letter of Intent (LOI) Application Period Submit abstract, biosketch and Mentor's Statement of Support. LOI applications are due March 12 . LOI applications are reviewed.
Applicants will be notified in early April whether they move forward to the full application. Accepted Applicants Complete Full Application This includes a research and budget plan, a description of facilities, a mentor’s statement of support, a mentor’s bio sketch, an institutional letter of support, and two personal references. Fellowship recipients are selected and notified.
SITC-Genmab Cancer Immunotherapy in Hematologic Malignancies: DLBCL, FL, and CLL Translational Fellowship This fellowship supports an MD, PhD or combined MD/PhD with a vested interest in furthering cancer immunotherapy research and translational immunotherapeutic approaches for the treatment of DLBCL, FL, and CLL.
SITC-Merck Cancer Immunotherapy Clinical Fellowship This clinical fellowship supports an MD or combined MD/PhD with a vested interest in furthering cancer immunotherapy research and translational immunotherapeutic approaches. SITC Cancer Immunotherapy Fellowship This fellowship supports clinical or translational research in cancer immunotherapy and will be awarded to an MD, PhD or combined MD/PhD.
For a PDF version of the fellowship guidelines, please click here . The SITC Awards Review Committee oversees the selection process, which begins with a Letter of Intent (LOI) as the initial stage of applications. Following the LOI review, selected applicants will be invited to submit full applications.
Notifications for each stage will be communicated via email. The SITC Fellowship Letter of Intent Application will be due on March 12, 2025. Any one-year fellowship terms will begin on Sept.
1, 2025 and will end on Aug. 31, 2026. Applicants that submit their LOI will be notified if they have been accepted to submit a full application in early April.
Full application submission notifications will come out June/July of 2025. Acceptance of a fellowship award presented by SITC does not preclude the grant recipient from obtaining grant support from other sources. The applicant and the sponsoring institution of the award recipient are responsible for ensuring that the terms of the SITC award are compatible with grant support from other sources, if applicable.
SITC Membership Requirement All SITC fellowship applicants must be SITC members in good standing at the time of LOI submission (i.e., current in dues). Individuals with student memberships are eligible to apply and student membership rates start as low as $50. Access more information on SITC membership and apply to join SITC here .
If your SITC membership application is submitted before the LOI deadline, the membership requirement of the Fellowship application will be fulfilled (pending any modifications, outstanding details or incorrect information). Please continue with your application submission. Contact info@sitcancer.
org with any questions. Minimum Percentage Requirement There is not a minimum percentage of workday as an eligibility criterion for these opportunities. Stage 1: Letter of Intent (LOI) : In the initial stage, applicants are required to submit a completed application form, an abstract, a biosketch, and a Mentor’s Statement of Support.
The Awards Review Committee will review LOI’s and will determine which applicants move to the second stage. Stage 2: Full Application : Applicants that are selected to move onto the second stage will be notified according to the timeline on the Fellowships webpage .
Applicants selected to for the second stage will need to provide a research and budget plan, a description of facilities, a mentor’s statement of support, a mentor’s bio sketch, an institutional letter of support, and two personal references. Applicants may meet the criteria for more than one fellowship, and applicants are welcome to apply for all fellowships for which they are eligible. Applicants will only be awarded one fellowship.
Applicants must submit a separate application for each fellowship they wish to apply for. I. Abstract (1 page) The abstract should outline the project’s aims, expected outcomes, and overall impact.
It must include the team members and explain how this award will assist the applicant in securing their next grant. II. Biosketch/Credentials (up to 5 pages) NIH Biosketch format, instructions and samples available here .
Use the “non-fellowship” format. Add this section at the end of the document to disclose additional research funding: Additional Information: Research Support III. Mentor’s Statement of Support (maximum 2 pages) This letter should be from the individual acting as a fellowship mentor to the applicant.
It must clearly present: The applicant’s role and academic appointment(s), the sponsor’s role in the proposed research, including plans to provide support as necessary, and plans and potential for the applicant to develop into an independently funded investigator. Full Application Required Documents I.
Applicant’s Statement of Purpose (maximum 2 pages) This letter should outline the award and career objectives of the applicant toward cancer immunotherapy research. This letter should specify: • Current and future cancer immunotherapy research objectives • Further training requested by the candidate II. Mentor’s Biosketch (maximum 5 pages) NIH Biosketch format, instructions and samples available here .
III. Institutional Letter of Support (maximum 2 pages) The letter must be written on letterhead by the department head, dean, or other senior member of the institution on behalf of the applicant. It should explain the applicant's relationship with the institution, and the nature and extent of support for the proposed research available from the institution, including laboratory space, financials and other resources.
IV. Research Plan and Budget Required Formatting: Calibri 11pt, Single Spaced, 1-inch margins. Figures do not count towards section page limits.
The research plan should include a thorough statement of the candidate’s proposed research plan in cancer immunotherapy, including: a) Specific aims (maximum 1 page) b) Background and significance (maximum 1. 5 pages) c) Preliminary results (if applicable) (maximum 1. 5 pages) d) Methods and procedures (maximum 4 pages) e) Anticipated outcome (maximum 1 page) f) Long-range objectives (maximum .
5 page) h) Research project budget (Note: The budget should outline the anticipated spend of the award among salary, research and other associated costs. The fellowship amounts must be entirely designated to salary, including support for equipment & supplies.) (maximum 1 page) V.
Facilities (maximum 1 page) Required Formatting: Calibri 11pt, Single Spaced, 1-inch margins. A description of the facilities for research and training needed by the candidate must be included. VI.
Two Personal References (maximum 2 pages each) Two letters of recommendation from two people familiar with the candidate’s qualifications must be included with the application. Currently, we do not have an example application or template. Please refer to the Award Overview documents for details on the application material requirements.
Our application portal, Proposal Central, will inform you of all necessary requirements to fulfill your application. Mentor Biosketch and Statement of Support Uploads SITC encourages referrers to send their letters of support and the mentor’s Biosketch to applicants who should then upload these directly to the application portal as a part of their application.
Mentor Sponsoring Multiple Applicants SITC does not restrict mentors from supporting multiple applicants for multiple fellowships. Only one applicant will be selected for each fellowship. Applicants are welcome to list up to two mentors and there is an option in the application portals to list both mentors.
Applicants with co-mentors can submit both mentors’ Biosketches and both mentors can write statements of support. Alternatively, the two mentors can write a joint letter of support. Mentor as Additional Reference Applicants are encouraged to have two people other than their mentor serve as the two personal references.
Fellowship applications are accessible by SITC staff for administrative purposes and are shared with Awards Review Committee members for the purposes of review only. All staff, fellowship reviewers and committee members agree to adhere to SITC's confidentiality policy, and as such all individuals privy to information shared in fellowship applications will keep the application information confidential.
Intellectual Property Guidelines SITC fellowship recipients and/or sponsoring institutions retain ownership of their work and research. Recipients of a SITC presented fellowship are required to submit a mid-term report and a final report detailing the status of their research. The report includes a write-up of the progress that has been made, as well as a financial accounting of funds.
At this time, there is not a template for the fellowship mid-term and final reports. However, the following items are required to be submitted: Mid-term Report Requirements: 1. Project title, award amount, recipient’s name 2.
Brief overview of the project progress to date 3. Describe highlights related to the award (presentation, publication, abstract, etc.) 4. Outcomes determined at this date Final Report Requirements: 1.
List the original specific aims of project. If the aims have changed, please explain. 2.
Synopsis of research progress to date 3. Abstracts or other publications resulting from the research project (please provide copy) 4. Any additional pending funding resulting from the studies performed in this research project (title of grant, PI, amount, duration, and agency) 5.
Plans after the award term SITC Fellowship Fund Usage The fellowship amounts are entirely designated to salary, including support for equipment & supplies. Indirect costs are not covered by SITC fellowships. Fellowship funds cannot be used to support travel to conferences or events.
Fellowship recipients receive complimentary registration and travel reimbursement to attend the SITC Annual Meeting in the year the fellowship is awarded. Currently, there is not a SITC fellowship budget template. However, the proposed budget must account for the entire award amount and can only be designated to allowable expenses.
Allowable expenses include salary support for the fellow, as well as necessary equipment and supplies required to carry out the project effectively. There is no percentage requirement for funds allocated for salary. However, the proposed budget must account for the entire award and can only be designated to allowable expenses.
Allowable expenses include salary support for the fellow, as well as necessary equipment and supplies required to carry out the project effectively. SITC fellowship funds may not be allocated to overhead costs or indirect costs. Changes to Proposal/Budget/Timeline/Institution/Role If at the end of the award term there are funds remaining, recipients may submit a No-Cost Extension request to education@sitcancer.
org . Requests are subject to approval by the SITC’s Executive Committee, and must be submitted at least 60 days prior to the end of the award term. Switching Institutions/Positions All fellowship applicants should submit applications based on their current role at their current institution.
If an awardee switched institutions, please send an update to SITC at education@sitcancer. org . SITC-Named Fellowship Terms • Receipt of this award does not preclude the applicant from obtaining grant support from other sources.
Support from the fellowship award is to be acknowledged in presentations and publications resulting from the research sponsored by the award. • The award is nontransferable. The award recipient will carry out the project as proposed in the application, in accordance with the timeline and budget in the application.
The award recipient is directly responsible as an employee to the supporting academic institution. The sponsoring institution is responsible for documenting their role in terms of supporting the education and research efforts as well as providing adequate research capacity, including space and equipment, for the award.
The sponsoring institution of the selected awardee is also responsible for ensuring that the terms of this award are compatible with grant support from other sources, if applicable. • SITC may discontinue the award if it is documented that the purpose or the terms of the award are not being fulfilled. In this event, the recipient will be notified in writing of this determination, the reason and the effective date.
• The recipient must submit a halfway point and a final written progress report to SITC, including disposition of funds. Any unused funds will be returned to SITC. The recipient is invited to submit an abstract during the regular abstract submission process for the chance to present the final results of his/her research at a SITC Annual Meeting.
View Past SITC Fellowship Recipients 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: info@sitcancer. org
Key questions and narrative sections extracted from the solicitation.
Letter of Intent with abstract (Stage 1)
Biosketch (Stage 1)
Mentor statement (Stage 1)
Full research plan (Stage 2)
Budget (Stage 2)
Institutional support letter (Stage 2)
According to the current listing, eligibility includes: Supports an MD or combined MD/PhD with a vested interest in furthering cancer immunotherapy research and translational immunotherapeutic approaches. Confirm the full requirements in the official notice before applying.
The current listing shows $50,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was January 1, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
SITC-Merck Cancer Immunotherapy Clinical Fellowship is funded by Society for Immunotherapy of Cancer (SITC) in partnership with Merck. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The Gates Foundation committed at least $1 billion over two years to equitable AI alongside its 10th Goalkeepers Report — 40% education, 40% health, 10% agriculture, 10% digital infrastructure. Five days later, 60 organizations signed a five-year goal to reach 3.4 billion speakers of underrepresented languages. Here is how implementing nonprofits should read both.
Read articleNEA's FY2027 Partnership Agreement Grants (2027NEA04PA) put $59 million into 56 state arts agencies with a September 29, 2026 deadline. No individual arts nonprofit can apply. But this is the channel through which most NEA dollars actually reach small organizations — and the supplanting rule and 1-to-1 state cost share determine how much reaches yours.
Read articleDARPA's DIAL program already had AI rediscover the Kalman filter and wavelets from scratch. SPEED DIAL (DPA26TZ05-DV003) funds the unglamorous next step: turning algorithm discovery into a tool that plugs into MATLAB, Simulink, and COMSOL. Up to $750,000 base plus a $1.25 million option, Direct to Phase II only, with a three-accomplishment feasibility gate and a mandatory university partner. Here is the milestone schedule, the interpretability requirement, and who is actually eligible.
Read article